62243-22-5 | Propanenitrile, 2-[[4-methoxy-6-(4-piperidinyl)-1,3,5-triazin-2-yl]amino]-2-methyl- | C13H20N6O |
62243-23-6 | Propanenitrile, 2-[[4-ethoxy-6-(4-piperidinyl)-1,3,5-triazin-2-yl]amino]-2-methyl- | C14H22N6O |
62243-24-7 | Propanenitrile, 2-[[4-methoxy-6-(4-morpholinyl)-1,3,5-triazin-2-yl]amino]-2-methyl- | C12H18N6O2 |
62243-48-5 | Benzoic acid, 3-(butylamino)-5-[[[(dimethylamino)methylene]amino]sulfonyl]-4-phenoxy -, methyl ester | C21H27N3O5S |
62243-50-9 | Benzoic acid, 3-[(3-chloropropyl)amino]-5-[[[(dimethylamino)methylene]amino]sulfonyl] -4-phenoxy-, methyl ester | C20H24ClN3O5S |
62243-54-3 | Benzoic acid, 3-amino-5-[[[(dimethylamino)methylene]amino]sulfonyl]-4-(4-methylphen oxy)-, methyl ester | C18H21N3O5S |
62243-64-5 | 8-Heptadecen-1-ol | C17H34O |
62243-74-7 | Morpholine, 2-[4-chloro-3-(trifluoromethyl)phenyl]-4-(1-methylethyl)-, hydrochloride | C14H17ClF3NO.ClH |
62243-76-9 | Morpholine, 2-[4-fluoro-3-(trifluoromethyl)phenyl]-4-(1-methylethyl)-, hydrochloride | C14H17F4NO.ClH |
62243-78-1 | Morpholine, 2-[3,5-bis(trifluoromethyl)phenyl]-4-(1-methylethyl)-, hydrochloride | C15H17F6NO.ClH |
62243-83-8 | 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-1,3-dihydro-, 4-oxide | C15H20ClN3O2 |
62243-84-9 | 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3,4,5-tetrahydro- 4-hydroxy- | C21H25ClFN3O2 |
62243-86-1 | Phosphonium, [(4-chlorophenyl)methyl](1,1-dimethylethyl)methylphenyl-, (S)-, tetraphenylborate(1-) | C24H20B.C18H23ClP |
62243-88-3 | Phosphonium, [(2-chlorophenyl)methyl](1,1-dimethylethyl)methylphenyl-, (R)-, tetraphenylborate(1-) | C24H20B.C18H23ClP |
62243-90-7 | Phosphonium, [(3-chlorophenyl)methyl](1,1-dimethylethyl)methylphenyl-, (R)-, tetraphenylborate(1-) | C24H20B.C18H23ClP |
62243-92-9 | Phosphonium, methylphenylpropyl[[4-(trifluoromethyl)phenyl]methyl]-, (R)-, tetraphenylborate(1-) | C24H20B.C18H21F3P |
62243-94-1 | Phosphonium, (diphenylmethyl)methylphenylpropyl-, (R)-, tetraphenylborate(1-) | C24H20B.C23H26P |